Mansoura International Hospital Mansoura International Hospital

Slides:



Advertisements
Similar presentations
Update of Anemia management in chronic kidney disease What is still missing.
Advertisements

Anemia Guidelines and The Use of Erythropoietin in Turkey
1 Anemia of chronic disease = Anemia of chronic disorders (ACD)
Anemia in chronic kidney disease
Anemia and CKD An Update
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
MLAB Hematology Keri Brophy-Martinez
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
Iron Repletion in ESRD Saleem Bharmal 2/9/10.
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Intravenous Iron Supplementation and Chronic Kidney Disease Chloe Bierbower December 2, 2013.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
How to manage anaemia in HD patients
Diagnosis and evaluation of anemia in CKD/HD
History 2: 70 year old female
Anemias Rowa, Al-Ramahi.
Case # 4: 2011, OSHU: Gyne cancer…. 47 yo JW admitted with vaginal bleeding and uterine pain; an abnormal pap in 2006 had been ignored/ treated homeopathically.
ANEMIA September 17 th, 2011 Debra Wells BSN, RN, CNN.
CKD Dr;BASHARDOOST. CKD –SOME DEFINITIONS IRREVERSIBLE LOSS OF GFR CKD results when a disease process damages the structural or functional integrity of.
The graph is based on data submitted to the WHO as of June Global Prevalence of Hepatitis C Virus.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
CHAPTER 6: MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 21 st MDTR.
ANEMIA OF CHRONIC DISEASE (ACD)
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB. It is the commonest medical disorder of pregnancy. It is the commonest medical disorder of pregnancy. Physiological.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
Management of Anemia in CKD Patients 2012 KDIGO Update Dr. Shahram Taheri.
Anemia in Hemodialysis 1. 2 Etiology The anemia of chronic kidney disease (CKD) is primarily due to insufficient production of the glycoprotein hormone.
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 20 th MDTR Report 2012,
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Anemia.
The use of Ferinject® (ferric carboxymaltase) in the treatment of iron deficiency in patients with renal anaemia Dr D Farrugia Dr S Ramakrishna E Gibson.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
Erythropoietin for anemia of CRF.
Anemia of chronic disease = Anemia of chronic disorders (ACD) 1.
What we are missing 2012 KDIGO guideline. Anemia.
( 수 ) 신장내과 전임의 한선애 TREATING ANEMIA IN CKD.
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Medical Directorate, National Kidney Foundation, Singapore
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Algorithm for management of anemia of CKD in adults
Claudia Beals, MD John Detesco Erdal Sarac, MD FACP FASN
Algorithm for iron therapy in management of anemia of CKD
Chapter 2: Clinical Indicators and Preventive Care
CPR 1.1. Identifying Patients and Initiating Evaluation
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB.
New and Emerging Management Options for Anemia in CKD
New options for the anemia of chronic kidney disease
Iron status and iron supplementation in peritoneal dialysis patients
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.
Anemia of chronic disease =Anemia of chronic disorders (ACD)
Volume 2: End-Stage Renal Disease
Volume 88, Issue 5, Pages (November 2015)
CREATE: Baseline values
Managing CKD-Associated Anemia in Challenging Patients
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Red Blood Cell Disorders
Volume 68, Issue 6, Pages (December 2005)
Recent experience with high-dose intravenous iron administration
Francesco Locatelli, Lucia Del Vecchio  Kidney International 
Volume 55, Issue 5, Pages (May 1999)
(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E
Volume 62, Issue 6, Pages (December 2002)
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
Presentation transcript:

Mansoura International Hospital Mansoura International Hospital Anemia In CKD Patient Dr. Hamed Ezzat El-Eraky Nephrology Specialist Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital 16th December 2016

Mansoura International Hospital 16th December 2016

Mansoura International Hospital Anemia of CKD Normocytic Normochromic Presence of other type of anemia point to another cause rather than CKD (on top of CKD) Mansoura International Hospital 16th December 2016

Nephrology Department Mansoura International Hospital Role of kidney in RBCs formation Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Anemia in chronic renal failure Mansoura International Hospital 16th December 2016

Nephrology Department Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Anemia in chronic renal failure ANEMİA Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Initial Evaluation of the patient Reticulocyte count : If > 130,000/l → look for: blood loss or hemolysis (endoscopy, colonoscopy, hemolysis screen) Fe Deficiency when: S. Ferritin  500 ng/ml S.TSAT  30% Occult blood in stool CRP: Exclude infection Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Treatment of anemia Adequate dialysis Iron supplementation Adequate nutrition Target Hb/Hct Level Prevention of inflammation ERYTHROPOIETIN Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital No Hematology work-up Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Target iron level The patients should have sufficient iron to achieve and maintain an Hb of 10 - 11.5 g/dl Serum ferritin  > 100 ng/ml OPTIMAL  200-500 ng / ml Transferrin saturation  > 20 OPTIMAL  30-40 Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Nephrology Department Mansoura International Hospital Administration of supplemental iron Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Initial erythropoietin administration SC ESAs Initiation Caution (malignancy, stroke history) Transfusion!! IV CKD ND CKD HD  10 g/dl (no treatment) < 10 g/dl (treat) < 10 g/dl (according) Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Titration of erythropoietin dosage Mansoura International Hospital 16th December 2016

Nephrology Department Mansoura International Hospital Titration of ESA Serum Hb After 2 weeks of starting initiation If Hb increases >1 g/dL If Hb increase by less than 1g/dL Increase dose by 25% Decrease dose by 25% Repeat serum Hb after another 2 weeks If Hb increase by less than 1g/dL Increase dose by 25% Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Blood Transfusion Blood Transfusion Avoid, when possible Mansoura International Hospital 16th December 2016

Mansoura International Hospital Mansoura International Hospital Nephrology Department Mansoura International Hospital Blood Transfusion Avoid, when possible Mansoura International Hospital 16th December 2016

it is better to get a Hb target in the 9.0 to 11.5 gm/dL. Nephrology Department Mansoura International Hospital Anemia due to CKD develops when GFR declines to less than 30 mL/min normalizing the Hb level of patients with CKD with ESAs is associated with poor outcomes it is better to get a Hb target in the 9.0 to 11.5 gm/dL. • don’t target Hb rise at initiation more than 1-2 g/dl/month Mansoura International Hospital 16th December 2016

Nephrology Department Mansoura International Hospital 16th December 2016